Impaired health-related quality of life in long-COVID syndrome after mild to moderate COVID-19

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: Online-Ressource, 1 online resource.

Language: Englisch

Bibliographic citation: Impaired health-related quality of life in long-COVID syndrome after mild to moderate COVID-19 ; volume:13 ; number:1 ; day:12 ; month:5 ; year:2023 ; pages:1-11 ; date:12.2023
Scientific reports ; 13, Heft 1 (12.5.2023), 1-11, 12.2023

Creator: Malesevic, Stefan
Sievi, Noriane A.
Baumgartner, Patrick
Roser, Katharina
Sommer, Grit
Schmidt, Dörthe
Vallelian, Florence
Jelcic, Ilijas
Clarenbach, Christian F.
Kohler, Malcolm

Contributor: SpringerLink (Online service)

DOI: 10.1038/s41598-023-34678-8

URN: urn:nbn:de:101:1-2023090808195280414767

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.03.2023, 4:01 AM CET

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Malesevic, Stefan
Sievi, Noriane A.
Baumgartner, Patrick
Roser, Katharina
Sommer, Grit
Schmidt, Dörthe
Vallelian, Florence
Jelcic, Ilijas
Clarenbach, Christian F.
Kohler, Malcolm
SpringerLink (Online service)

Other Objects (12)

Neurological manifestations in mild and moderate cases of COVID-19

Combined Metabolic Activators Accelerates Recovery in Mild‐to‐Moderate COVID‐19

Electroencephalogram-based evaluation of impaired sedation in patients with moderate to severe COVID-19 ARDS

Cognitive performance of post-covid patients in mild, moderate, and severe clinical situations

Impaired dendritic cell homing in COVID-19

Health-related quality of life in mild-to-moderate COVID-19 in the UK: a cross-sectional study from pre- to post-infection

COVID-19: Thromboembolien auch bei moderaten Verläufen

Impaired fibrinolysis in critically ill COVID-19 patients

Association of neuronal injury blood marker neurofilament light chain with mild-to-moderate COVID-19

Considerations for Return to Exercise Following Mild-to-Moderate COVID-19 in the Recreational Athlete

A randomized phase 2 study on demeclocycline in patients with mild-to-moderate COVID-19

Glycyrrhizin and boswellic acids, the golden nutraceuticals: multitargeting for treatment of mild–moderate COVID-19 and prevention of post-COVID cognitive impairment

Neurological manifestations in mild and moderate cases of COVID-19

Combined Metabolic Activators Accelerates Recovery in Mild‐to‐Moderate COVID‐19

Electroencephalogram-based evaluation of impaired sedation in patients with moderate to severe COVID-19 ARDS

Cognitive performance of post-covid patients in mild, moderate, and severe clinical situations

Impaired dendritic cell homing in COVID-19

Health-related quality of life in mild-to-moderate COVID-19 in the UK: a cross-sectional study from pre- to post-infection

COVID-19: Thromboembolien auch bei moderaten Verläufen

Impaired fibrinolysis in critically ill COVID-19 patients

Association of neuronal injury blood marker neurofilament light chain with mild-to-moderate COVID-19

Considerations for Return to Exercise Following Mild-to-Moderate COVID-19 in the Recreational Athlete

A randomized phase 2 study on demeclocycline in patients with mild-to-moderate COVID-19

Glycyrrhizin and boswellic acids, the golden nutraceuticals: multitargeting for treatment of mild–moderate COVID-19 and prevention of post-COVID cognitive impairment

Neurological manifestations in mild and moderate cases of COVID-19

Combined Metabolic Activators Accelerates Recovery in Mild‐to‐Moderate COVID‐19

Electroencephalogram-based evaluation of impaired sedation in patients with moderate to severe COVID-19 ARDS

Cognitive performance of post-covid patients in mild, moderate, and severe clinical situations

Impaired dendritic cell homing in COVID-19

Health-related quality of life in mild-to-moderate COVID-19 in the UK: a cross-sectional study from pre- to post-infection

COVID-19: Thromboembolien auch bei moderaten Verläufen

Impaired fibrinolysis in critically ill COVID-19 patients

Association of neuronal injury blood marker neurofilament light chain with mild-to-moderate COVID-19

Considerations for Return to Exercise Following Mild-to-Moderate COVID-19 in the Recreational Athlete

A randomized phase 2 study on demeclocycline in patients with mild-to-moderate COVID-19

Glycyrrhizin and boswellic acids, the golden nutraceuticals: multitargeting for treatment of mild–moderate COVID-19 and prevention of post-COVID cognitive impairment

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Impaired health-related quality of life in long-COVID syndrome after mild to moderate COVID-19

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Neurological manifestations in mild and moderate cases of COVID-19

Combined Metabolic Activators Accelerates Recovery in Mild‐to‐Moderate COVID‐19

Electroencephalogram-based evaluation of impaired sedation in patients with moderate to severe COVID-19 ARDS

Cognitive performance of post-covid patients in mild, moderate, and severe clinical situations

Impaired dendritic cell homing in COVID-19

Health-related quality of life in mild-to-moderate COVID-19 in the UK: a cross-sectional study from pre- to post-infection

COVID-19: Thromboembolien auch bei moderaten Verläufen

Impaired fibrinolysis in critically ill COVID-19 patients

Association of neuronal injury blood marker neurofilament light chain with mild-to-moderate COVID-19

Considerations for Return to Exercise Following Mild-to-Moderate COVID-19 in the Recreational Athlete

A randomized phase 2 study on demeclocycline in patients with mild-to-moderate COVID-19

Glycyrrhizin and boswellic acids, the golden nutraceuticals: multitargeting for treatment of mild–moderate COVID-19 and prevention of post-COVID cognitive impairment

Neurological manifestations in mild and moderate cases of COVID-19

Combined Metabolic Activators Accelerates Recovery in Mild‐to‐Moderate COVID‐19

Electroencephalogram-based evaluation of impaired sedation in patients with moderate to severe COVID-19 ARDS

Cognitive performance of post-covid patients in mild, moderate, and severe clinical situations

Impaired dendritic cell homing in COVID-19

Health-related quality of life in mild-to-moderate COVID-19 in the UK: a cross-sectional study from pre- to post-infection

COVID-19: Thromboembolien auch bei moderaten Verläufen

Impaired fibrinolysis in critically ill COVID-19 patients

Association of neuronal injury blood marker neurofilament light chain with mild-to-moderate COVID-19

Considerations for Return to Exercise Following Mild-to-Moderate COVID-19 in the Recreational Athlete

A randomized phase 2 study on demeclocycline in patients with mild-to-moderate COVID-19

Glycyrrhizin and boswellic acids, the golden nutraceuticals: multitargeting for treatment of mild–moderate COVID-19 and prevention of post-COVID cognitive impairment

Neurological manifestations in mild and moderate cases of COVID-19

Combined Metabolic Activators Accelerates Recovery in Mild‐to‐Moderate COVID‐19

Electroencephalogram-based evaluation of impaired sedation in patients with moderate to severe COVID-19 ARDS

Cognitive performance of post-covid patients in mild, moderate, and severe clinical situations

Impaired dendritic cell homing in COVID-19

Health-related quality of life in mild-to-moderate COVID-19 in the UK: a cross-sectional study from pre- to post-infection

COVID-19: Thromboembolien auch bei moderaten Verläufen

Impaired fibrinolysis in critically ill COVID-19 patients

Association of neuronal injury blood marker neurofilament light chain with mild-to-moderate COVID-19

Considerations for Return to Exercise Following Mild-to-Moderate COVID-19 in the Recreational Athlete

A randomized phase 2 study on demeclocycline in patients with mild-to-moderate COVID-19

Glycyrrhizin and boswellic acids, the golden nutraceuticals: multitargeting for treatment of mild–moderate COVID-19 and prevention of post-COVID cognitive impairment

Related objects

Reset password